CATALYST PHARMACEUTICALS INC

Ticker: CPRX CUSIP: 14888U101 Class: Common Stock

Qube Research & Technologies Ltd's Holding History (CIK: 0001729829)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 487,135 Value ($000) $11,370 Avg Close $22.28 Range $19.90 - $25.14
Q3 2025
Shares 821,202 Value ($000) $16,178 Avg Close $20.57 Range $19.05 - $22.53
Q2 2025
Shares 1,014,410 Value ($000) $22,013 Avg Close $23.61 Range $20.40 - $26.58
Q1 2025
Shares 760,296 Value ($000) $18,437 Avg Close $22.52 Range $19.15 - $26.16
Q4 2024
Shares 659,252 Value ($000) $13,759 Avg Close $21.48 Range $19.54 - $24.27
Q3 2024
Shares 667,240 Value ($000) $13,265 Avg Close $18.54 Range $14.97 - $21.67
Q2 2024
Shares 128,734 Value ($000) $1,994 Avg Close $15.57 Range $14.47 - $17.03
Q1 2024
Shares 90,250 Value ($000) $1,439 Avg Close $15.07 Range $13.12 - $17.50
Q3 2023
Shares 64,578 Value ($000) $755 Avg Close $13.38 Range $11.59 - $15.59
Q4 2022
Shares 121,873 Value ($000) $2,267 Avg Close $15.40 Range $12.08 - $19.78
Q2 2022
Shares 122,638 Value ($000) $860 Avg Close $7.33 Range $6.15 - $8.65
Q1 2022
Shares 153,709 Value ($000) $1,274 Avg Close $7.07 Range $5.24 - $8.64
Q4 2021
Shares 178,320 Value ($000) $1,207 Avg Close $6.58 Range $5.05 - $7.58
Q3 2021
Shares 84,502 Value ($000) $448 Avg Close $5.47 Range $4.81 - $6.24
Q2 2021
Shares 44,264 Value ($000) $255 Avg Close $5.16 Range $4.21 - $6.22
Q1 2020
Shares 34,024 Value ($000) $131 Avg Close $4.10 Range $2.55 - $5.28